Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial - Vranckx, P; Valgimigli, M; Eckardt, J (Lancet, 2019)
et al.